Recursion Pharmaceuticals: fresh buy with 76 strength and a sector in gear

Recursion Pharmaceuticals opens a fresh buy signal, 7th among the 10 fresh Longs for US stocks, with a signal strength of 76 out of 100. The technical picture is wide but volatile: high conviction, ample move, to be managed with discipline. Behind it, a double bottom with a 44% rebound, and a Health Care sector up nearly 12% over the past month. The entry stays cautious: the stock has not yet attacked its recent highs.